Iberverin is a naturally occurring sesquiterpene lactone isolated from the roots of the plant Iberis amara. It exhibits anti-inflammatory and analgesic properties, making it a promising candidate for the treatment of inflammatory conditions such as rheumatoid arthritis and osteoarthritis. Iberverin has shown to inhibit the production of pro-inflammatory cytokines, such as TNF-alpha and IL-1beta, and to suppress the activation of NF-kappaB, a key transcription factor involved in inflammation. The synthesis of iberverin is a complex process, involving multiple steps and starting from readily available natural products. Iberverin is a potent anti-inflammatory agent and has the potential to be developed into a novel therapeutic drug for the treatment of inflammatory diseases.'
ID Source | ID |
---|---|
PubMed CID | 62351 |
CHEMBL ID | 3186484 |
SCHEMBL ID | 668271 |
MeSH ID | M0587571 |
Synonym |
---|
3-methylthiopropyl |
3-methylthiopropyl isothiocyanate |
propane, 1-isothiocyanato-3-(methylthio)- |
3-methylmercaptopropyl isothiocyanate |
einecs 208-020-3 |
isothiocyanic acid, 3-(methylthio)propyl ester |
1-isothiocyanato-3-(methylthio)propane |
fema no. 3312 |
3-(methylthio)propyl isothiocyanate, >=98%, fg |
505-79-3 |
3-(methylthio)propyl isothiocyanate |
isothiocyanic acid 3-(methylthio)propyl ester |
M2027 |
1-isothiocyanato-3-methylsulfanylpropane |
AKOS000120740 |
tox21_302609 |
dtxsid3047132 , |
cas-505-79-3 |
NCGC00256650-01 |
dtxcid1027132 |
A828183 |
1-isothiocyanato-3-methylsulfanyl-propane |
ytt13bn94z , |
unii-ytt13bn94z |
iberverin , |
BP-12929 |
FT-0616194 |
3-methylthiopropyl isothiocyanate [fhfi] |
3-methylsulfanylpropylisothiocyanate |
1-isothiocyanato-3-(methylsulfenyl)-propane |
radish isothiocyanate |
SCHEMBL668271 |
1-isothiocyanato-3-(methylsulfanyl)propane # |
LDKSCZJUIURGMW-UHFFFAOYSA-N |
W-105949 |
CHEMBL3186484 , |
mfcd00209521 |
1-isothiocyanato-3-(methylsulfanyl)propane |
ibervirin |
bdbm50104731 |
fema 3312 |
1-isothiocyanato-3-(methylthio)-propane |
iberverin, 97% |
(3-isothiocyanatopropyl)(methyl)sulfane |
EN300-21339 |
3-(methylthio)propylisothiocyanate |
Q27294710 |
D91571 |
3-butanoic s-based propyl isothiocyanates were ester |
Z104495408 |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 61.6448 | 3.1890 | 29.8841 | 59.4836 | AID1224846 |
AR protein | Homo sapiens (human) | Potency | 23.8784 | 0.0002 | 21.2231 | 8,912.5098 | AID1259243; AID1259247 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 43.6412 | 0.0002 | 14.3764 | 60.0339 | AID720692 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 76.9588 | 0.0030 | 41.6115 | 22,387.1992 | AID1159553 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 54.4827 | 0.0015 | 30.6073 | 15,848.9004 | AID1224849 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 59.9206 | 0.3758 | 27.4851 | 61.6524 | AID743220; AID743239 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 58.3002 | 0.0002 | 29.3054 | 16,493.5996 | AID743075; AID743080; AID743091 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 58.2929 | 0.0010 | 19.4141 | 70.9645 | AID743140; AID743191 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 61.1306 | 0.0017 | 23.8393 | 78.1014 | AID743083 |
activating transcription factor 6 | Homo sapiens (human) | Potency | 16.1374 | 0.1434 | 27.6121 | 59.8106 | AID1159516; AID1159519 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 54.9410 | 19.7391 | 45.9784 | 64.9432 | AID1159509 |
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 65.7208 | 0.0003 | 23.4451 | 159.6830 | AID743065; AID743067 |
heat shock protein beta-1 | Homo sapiens (human) | Potency | 19.4938 | 0.0420 | 27.3789 | 61.6448 | AID743210 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 47.0939 | 0.0006 | 27.2152 | 1,122.0200 | AID743202; AID743219 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 55.5485 | 0.0023 | 19.5956 | 74.0614 | AID651631; AID720552 |
ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 57.8067 | 0.0119 | 17.9420 | 71.5630 | AID651632; AID720516 |
Ataxin-2 | Homo sapiens (human) | Potency | 54.4827 | 0.0119 | 12.2221 | 68.7989 | AID651632 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | EC50 (µMol) | 0.4500 | 0.0003 | 3.1662 | 10.0000 | AID1235910 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.79) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |